by Igen BioLab Group | Feb 25, 2020 | News
Checkpoint inhibitors have revolutionized cancer therapy but only work in a subset of patients and can lead to a multitude of toxicities, suggesting the need for more targeted delivery systems. Because of their preferential colonization of tumors, microbes are a...
by Igen BioLab Group | Jan 21, 2020 | News
The next frontier in microbiome research Diseases intrinsic to the pancreas such as pancreatitis, pancreatic cancer and type 1 diabetes mellitus impart substantial health and financial burdens on society but identification of novel mechanisms contributing to these...
by Igen BioLab Group | Jan 14, 2020 | News
More than a decade after the launch of the Human Microbiome Project, research in this field has grown exponentially, with studies associating microbial states or species with disorders including novel infectious etiologies and complex human disease. Scientists are...
by Igen BioLab Group | Jan 7, 2020 | News
The human microbiome has not only captured the attention of scientists, but also of health professionals and the lay press. Although initial studies focused on characterizing the intestinal microbiome in the context of health and disease and the influence of...
by Igen BioLab Group | Dec 30, 2019 | News
The mucus layer in the human colon protects against commensal bacteria and pathogens, and defects in its unique bilayered structure contribute to intestinal disorders, such as ulcerative colitis. However, our understanding of colon physiology is limited by the lack of...